Trius Therapeutics Inc - FORM 10-Q - EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - May 6, 2011

Attached files

file filename
10-Q - FORM 10-Q - Trius Therapeutics Incd10q.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Trius Therapeutics Incdex311.htm
EX-31.2 - CERTIFICATION OF VICE PRESIDENT FINANCE AND CHIEF ACCOUNTING OFFICER - Trius Therapeutics Incdex312.htm
EX-10.1 - SEVENTH AMENDMENT - Trius Therapeutics Incdex101.htm
EX-32.2 - CERTIFICATION OF VICE PRESIDENT FINANCE AND CHIEF ACCOUNTING OFFICER - Trius Therapeutics Incdex322.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Trius Therapeutics, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jeffrey Stein, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/S/    JEFFREY STEIN        

Jeffrey Stein, Ph.D.

Chief Executive Officer

(Principal Executive Officer)

May 6, 2011

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Trius Therapeutics Inc Reports